TABLE 1

BOPTA and MEB pharmacokinetic parameters and concentrations in the presence of RIF (+RIF) and the absence of RIF (−RIF)

ParametersBOPTABOPTA+RIF+RIF/−RIF RatioMEBMEB+RIF+RIF/−RIF Ratio
Cin (μM)2002006464
Cout,75min (μM)185 ± 3196 ± 21.065 ± 231 ± 46.2
CHC,75min (μM)566 ± 9923 ± 190.042611 ± 4985044 ± 6931.93
Cbile,75min (μM)16,791 ± 208592 ± 440.000597,017 ± 11,28913,258 ± 83630.14
Cbile,75min/CHC,75min30.6 ± 7.53.5 ± 2.90.1138.4 ± 8.82.6 ± 1.60.07
v75min (nmol/min)a464 ± 80111 ± 470.241797 ± 611022 ± 1130.57
CL (ml/min)b2.32 ± 0.400.56 ± 0.240.2428.12 ± 0.2215.64 ± 1.770.56
Ec0.08 ± 0.010.02 ± 0.010.250.93 ± 0.030.53 ± 0.060.57
vbile,75min (nmol/min)d390 ± 841 ± 10.003990 ± 166105 ± 650.11
fL CLint,bile (ml/min)e0.72 ± 0.230.04 ± 0.030.060.39 ± 0.110.02 ± 0.010.05
fL CLef (ml/min)f0.13–0.07g0.41–0.00g0.01 ± 0.010.01 ± 0.01
fB CLin (ml/min)2.69 ± 0.370.60 ± 0.200.2228.54 ± 0.2715.64 ± 1.770.55
  • a Drug removal rate from sinusoids (v) = QH ⋅ (Cin − Cout).

  • b Hepatic CL: QH ⋅ (Cin − Cout)/Cin.

  • c Extraction ratio (E) = Cin − Cout/Cin.

  • d vbile = Qbile ⋅ Cbile.

  • e CLint,bile (fL ⋅ CLint,bile) = vbile/CHC.

  • f CLef back to sinusoids (fL ⋅ CLef) = vef/CHC, with vef = QH ⋅ Cout.

  • g Mean ranges over time.